Clinical efficacy and safety: rheumatology/musculoskeletal system

The European Medicines Agency's scientific guidelines on clinical evaluation of human medicines used in disorders affecting the joints, bones, muscles and soft tissues help medicine developers prepare marketing authorisation applications.

If you have comments on a document which is open for consultation, use the .

Please submit your comments to the following email address:

For a complete list of scientific guidelines currently open for consultation, see Public consultations.


Concept papers

How useful was this page?

Add your rating
2 ratings